UROGEN PHARMA LTD has a total of 35 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are MEDRX CO LTD, NAL PHARMACEUTICAL GROUP LTD and BLUEBERRY THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | EPO (European Patent Office) | 12 | |
#3 | Israel | 6 | |
#4 | Australia | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Implantable devices | |
#4 | Syringes | |
#5 | Peptides | |
#6 | Enzymes | |
#7 | Special acyclic compounds | |
#8 | Diagnosis and surgery | |
#9 | Climate change adaptation technologies | |
#10 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Hakim Gil | 14 |
#2 | Konorty Marina | 13 |
#3 | Dollberg Yosh | 8 |
#4 | Malchi Nadav | 8 |
#5 | Pattarino Franco | 7 |
#6 | Maj Roberto | 7 |
#7 | Friedman Astar | 6 |
#8 | Strauss-Ayali Dalit | 6 |
#9 | Shpolansky Uri | 5 |
#10 | De La Zerda Jaime | 5 |
Publication | Filing date | Title |
---|---|---|
EP3498270A1 | Slow release formulations of cell cycle regulators and anti-cancer agents for local treatment of solid cancer | |
EP3532505A1 | Immunomodulating treatments of body cavities | |
WO2017115374A1 | A connectable catheter system | |
US2017136222A1 | A connectable catheter | |
EP3659603A1 | Pharmaceutical compositions comprising imiquimod for use in the treatment of carcinoma in situ of the bladder | |
US2014105884A1 | Material and method for treating internal cavities | |
EP2836200A2 | Reverse thermal hydrogel preparations for use in the treatment of disorders of the urothelium | |
IL221040D0 | Material and method for treating internal cavities | |
EP2734187A1 | Materials and method for treating internal body cavities |